A reverse chronological list of vaccine licensure announcements from FDA, vaccine recommendations from the Advisory Committee on Immunization Practices (ACIP) and CDC, and other resources from government sources. Use filters to narrow your search.
FDA approves Penbraya (PFR) for ages 10 through 25 years, a pentavalent vaccine protects against five meningococcal bacteria groups - A, B, C, W and Y - which are known to commonly cause the disease.
FDA Approval –
October 20, 2023